Inflammatory and viral cardiomyopathies

Authors: J. Kvasnička
Authors‘ workplace: Interní klinika, kardiologické oddělení ;  Krajská nemocnice, Pardubice
Published in: Kardiol Rev Int Med 2006, 8(1-2): 47-51
Category: Editorial


The aim of the short review of literature is to sum up the information on acute viral myocarditis and chronic dilated cardiomyopathy, with a focus on identifying the situations when viral or auto-immune causes and targeted therapy aimed at progression mechanisms should be considered.

acute inflammatory myocarditis – pathogenesis – diagnosis – chronic cardiomyopathy – myocardial biopsy


1. Aretz HT, Billingham ME, Edwards WD et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1: 3-14.

2. Archard LC, Bowles NE, Cunningham L et al. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur Heart J 1991; 12(Suppl D): 56-59.

3. Badorff C, Lee GH, Lamphear BJ et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999; 5: 320-326.

4. Baughman KL. Diagnosis of myocarditis. Death of Dallas criteria. Circulation 2006; 113: 593-595.

5. Baughman KL, Wynne J. Myocarditis. In: Zipes DP(ed) et al. Heart Diseased. Philadelphia: Elsevier-Saunders 2005: 1697-1718.

6. Bergelson JM, Cunningham JA, Droguett G et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.

7. Bowles NE, Ni J, Kearney DL et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003; 42: 466-472.

8. Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002; 4: 411-417.

9. Cooper LT jr. Myocarditits. In: Murphy JG (ed). Mayo clinic cardiology review. Baltiomore: Lippincott Williams&Wilkins 2000: 483-508.

10. Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol 1992; 19: 43-47.

11. Felix SB, Staudt A, Dorffel WV et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 2000; 35: 1590-1598.

12. Fujioka S, Kitaura Y, Ukimura A et al. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2000; 36: 1920-1926.

13. Frustaci A, Chimenti C, Calabrese F et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107: 857-863.

14. Goodwin JF. The frontiers of cardiomyopathy. Br Heart J 1982; 48: 1-18.

15. Hare JM, Baughman KL. Fulminant and acute lymphocytic myocarditis: the prognostic value of clinicopathological classification. Eur Heart J 2001; 22: 269-270.

16. Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child 2004; 89: 580-584.

17. Hufnagel G, Pankuweit S, Richter A et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 2000; 3: 279-285.

18. Kishimoto C, Shioji K, Kinoshita M et al. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int J Cardiol 2003; 91: 173-178.

19. Knowlton KU. Unsolved medical issues and new targets for further research in viral myocarditis and dilated cardiomyopathy. Ernst Schering Res Found Workshop 2006; 55: 19-35.

20. Kuhl U, Pauschinger M, Noutsias M et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 2005; 111: 887-893.(epub 2005 Feb 7).

21. Kuhl U, Pauschinger M, Schwimmbeck PL et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003; 107: 2793-2798.

22. Lim BK, Shin JO, Choe SC et al. Myocardial injury occurs earlier than myocardial inflammation in acute experimental viral myocarditis. Exp Mol Med 2005; 37: 51-57.

23. Liu C, Chen J, Liu K. Immunosuppressive treatment for inflammatory cardiomyopathy: meta-analysis of randomized controlled trials. Int Heart J 2005; 46: 113-122.

24. Maisch B, Hufnagel G, Kolsch S et l. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 2004; 29: 624-636. Review.

25. Maisch B, Hufnagel G, Schonian U, Hengstenberg C. European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). Eur Heart J 1995; 16(Suppl O): 173-175.

26. Mason JW, O'Connell JB, Herskowitz A et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995; 333: 269-275.

27. Matsumori A, Tomioka N, Kawai C. Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice. Am Heart J 1988; 115: 1229-1232.

28. Menghini VV, Savcenko V, Olson LJ et al. Combined immunosuppression for the treatment of idiopathic giant cell myocarditis. Mayo Clin Proc 1999; 74: 1221-1226.

30. Mobini R, Staudt A, Felix SB et al. Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 2003; 20: 345-50.

31. Narula N, Narula J, Dec GW. Endomyocardial biopsy for non-transplant-related disorders. Am J Clin Pathol 2005; 123(Suppl): 106-118.

32. Niebauer J, Volk HD, Kemp M et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353(9167): 1838-1842.

33. Pankuweit S, Portig I, Lottspeich F, Maisch B. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 1997; 29: 77-84.

34. Pophal SG, Sigfusson G, Booth KL et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999; 34: 2105-2110.

35. Richardson P, McKenna W, Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-842.

36. Robinson JL, Hartling L, Crumley E et al. A systematic review of intravenous gamma globulin for therapy of acute myocarditis. BMC Cardiovasc Disord 2005; 5: 12.

37. Schultheiss H-P and Kuhl U. Myocarditis and inflammatory cardiomyopathy. In: Crawford MH, DiMarco JP, Paulus WJ (eds). Cardiology. Edinburgh: Mosby 2004: 937-949.

38. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001; 104: 39-45.

39. Wu LA, Lapeyre AC, Cooper LT. Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis. Mayo Clin Proc 2001; 76: 1030-1038.

40. Wynne J, Braunwald E. The cardiomyopathies. In: Zipes DP (ed) et al. Heart Disease. Philadelphia: Elsevier-Saunders 2005: 1659-1696.

Paediatric cardiology Internal medicine Cardiac surgery Cardiology
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account